SEC Filings | Apogee Therapeutics, Inc.

Filing Date	Form	Description	View
Jun 05, 2023	DRS/A	Amendment to a previously filed DRS	View HTML 0001104659-23-068124.pdf 0001104659-23-068124.rtf 0001104659-23-068124.xls
Apr 28, 2023	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	View HTML 0001104659-23-052736.pdf 0001104659-23-052736.rtf 0001104659-23-052736.xls

Data provided by Kaleidoscope.